Omnicell (OMCL) Stock Forecast & Price Target

Compare

344 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

OMCL Analyst Ratings

Strong Buy

6 Buy

1 Hold

0 Sell

Based on 7 analysts giving stock ratings to

Omnicell

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

OMCL Stock 12 Month Forecast

Average Price Target

$58.20

▲(48.93% Upside)

Based on 7 Wall Street analysts offering 12 month price targets for Omnicell in the last 3 months. The average price target is $58.20 with a high forecast of $70.00 and a low forecast of $49.00. The average price target represents a 48.93% change from the last price of $39.08.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"28":"$28","71":"$71","38.75":"$38.8","49.5":"$49.5","60.25":"$60.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":70,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$70.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":58.2,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$58.20</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":49,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$49.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[28,38.75,49.5,60.25,71],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2025","6":"Aug<br/>2025","9":"Nov<br/>2025","12":"Feb<br/>2026","25":"Feb<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,48.7,50.338461538461544,51.97692307692308,53.61538461538462,55.253846153846155,56.892307692307696,58.53076923076923,60.16923076923077,61.80769230769231,63.44615384615385,65.08461538461539,66.72307692307692,68.36153846153846,{"y":70,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,48.7,49.430769230769236,50.16153846153846,50.892307692307696,51.62307692307692,52.353846153846156,53.08461538461539,53.815384615384616,54.54615384615385,55.27692307692308,56.00769230769231,56.73846153846154,57.46923076923077,{"y":58.2,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,48.7,48.723076923076924,48.746153846153845,48.769230769230774,48.792307692307695,48.815384615384616,48.83846153846154,48.861538461538466,48.88461538461539,48.90769230769231,48.93076923076923,48.95384615384616,48.97692307692308,{"y":49,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":44.99,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":38.06,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":35.26,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":31.38,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":30.2,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":29.93,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":29.76,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":32.1,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":29.96,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 28, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":33.57,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 31, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":36.12,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 30, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":45.3,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 40, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":48.7,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 42, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$70.00

Average Price Target$58.20

Lowest Price Target$49.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Jessica Tassan

Piper Sandler

$63→$49

Buy

25.38%

Upside

Reiterated

02/06/26

Omnicell price target lowered to $49 from $63 at Piper SandlerOmnicell price target lowered to $49 from $63 at Piper Sandler

Allen Lutz

Bank of America Securities

$70

Buy

79.12%

Upside

Reiterated

02/05/26

Omnicell upgraded to Buy from Neutral at BofAOmnicell upgraded to Buy from Neutral at BofA

Matt Hewitt

Craig-Hallum

Buy

―

Reiterated

02/05/26

Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (NYSE: IQV), Omnicell (NASDAQ: OMCL) and MiMedx Group (NASDAQ: MDXG)

Stan Berenshteyn

Wells Fargo

$52

Buy

33.06%

Upside

Reiterated

02/05/26

Analysts Conflicted on These Healthcare Names: Cigna (NYSE: CI), Hims & Hers Health (NYSE: HIMS) and Omnicell (NASDAQ: OMCL)

David Larsen

BTIG

Hold

―

Reiterated

02/05/26

Omnicell: Solid Execution and Strategic Promise Offset by Near-Term Profitability Pressures and Premium Valuation (Hold Rating Maintained)

Bill Sutherland

Benchmark Co.

$50→$60

Buy

53.53%

Upside

Reiterated

02/02/26

Omnicell price target raised to $60 from $50 at BenchmarkOmnicell price target raised to $60 from $50 at Benchmark

Scott Schoenhaus

KeyBanc

$60

Buy

53.53%

Upside

Upgraded

01/08/26

Omnicell upgraded to Overweight from Sector Weight at KeyBancOmnicell upgraded to Overweight from Sector Weight at KeyBanc

Anne Samuel

J.P. Morgan

$36→$34

Hold

-13.00%

Downside

Reiterated

05/20/25

Omnicell (OMCL) Gets a Hold from J.P. Morgan

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Jessica Tassan

Piper Sandler

$63→$49

Buy

25.38%

Upside

Reiterated

02/06/26

Omnicell price target lowered to $49 from $63 at Piper SandlerOmnicell price target lowered to $49 from $63 at Piper Sandler

Allen Lutz

Bank of America Securities

$70

Buy

79.12%

Upside

Reiterated

02/05/26

Omnicell upgraded to Buy from Neutral at BofAOmnicell upgraded to Buy from Neutral at BofA

Matt Hewitt

Craig-Hallum

Buy

―

Reiterated

02/05/26

Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (NYSE: IQV), Omnicell (NASDAQ: OMCL) and MiMedx Group (NASDAQ: MDXG)

Stan Berenshteyn

Wells Fargo

$52

Buy

33.06%

Upside

Reiterated

02/05/26

Analysts Conflicted on These Healthcare Names: Cigna (NYSE: CI), Hims & Hers Health (NYSE: HIMS) and Omnicell (NASDAQ: OMCL)

David Larsen

BTIG

Hold

―

Reiterated

02/05/26

Omnicell: Solid Execution and Strategic Promise Offset by Near-Term Profitability Pressures and Premium Valuation (Hold Rating Maintained)

Bill Sutherland

Benchmark Co.

$50→$60

Buy

53.53%

Upside

Reiterated

02/02/26

Omnicell price target raised to $60 from $50 at BenchmarkOmnicell price target raised to $60 from $50 at Benchmark

Scott Schoenhaus

KeyBanc

$60

Buy

53.53%

Upside

Upgraded

01/08/26

Omnicell upgraded to Overweight from Sector Weight at KeyBancOmnicell upgraded to Overweight from Sector Weight at KeyBanc

Anne Samuel

J.P. Morgan

$36→$34

Hold

-13.00%

Downside

Reiterated

05/20/25

Omnicell (OMCL) Gets a Hold from J.P. Morgan

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Omnicell

3 Months

xxx

Success Rate

15/23 ratings generated profit

Average Return

+6.42%

reiterated a xxx

rating 5 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 65.22% of your transactions generating a profit, with an average return of +6.42% per trade.

1 Year

Bill SutherlandBenchmark Co.

Success Rate

15/23 ratings generated profit

Average Return

+19.02%

reiterated a buy rating 5 days ago

Copying Bill Sutherland's trades and holding each position for 1 Year would result in 65.22% of your transactions generating a profit, with an average return of +19.02% per trade.

2 Years

xxx

Success Rate

16/23 ratings generated profit

Average Return

+25.08%

reiterated a xxx

rating 5 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 69.57% of your transactions generating a profit, with an average return of +25.08% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

OMCL Analyst Recommendation Trends

Rating

Oct 25

Nov 25

Dec 25

Jan 26

Feb 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, OMCL has received 36 Buy Ratings, 42 Hold Ratings, and 0 Sell Ratings. OMCL average Analyst price target in the past 3 months is 58.20.

Each month's total comprises the sum of three months' worth of ratings.

OMCL Financial Forecast

OMCL Earnings Forecast

Next quarter’s earnings estimate for OMCL is $0.32 with a range of $0.29 to $0.35. The previous quarter’s EPS was $0.40. OMCL beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year OMCL has Performed in-line its overall industry.

OMCL Sales Forecast

Next quarter’s sales forecast for OMCL is $298.72M with a range of $280.97M to $307.42M. The previous quarter’s sales results were $313.98M. OMCL beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year OMCL has Performed in-line its overall industry.

OMCL Stock Forecast FAQ

What is OMCL’s average 12-month price target, according to analysts?

Based on analyst ratings, Omnicell’s 12-month average price target is 58.20.

What is OMCL’s upside potential, based on the analysts’ average price target?

Omnicell has 48.93% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is OMCL a Buy, Sell or Hold?

Omnicell has a consensus rating of Strong Buy which is based on 6 buy ratings, 1 hold ratings and 0 sell ratings.

What is Omnicell’s price target?

The average price target for Omnicell is 58.20. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $70.00 ,the lowest forecast is $49.00. The average price target represents 48.93% Increase from the current price of $39.08.

What do analysts say about Omnicell?

Omnicell’s analyst rating consensus is a Strong Buy. This is based on the ratings of 7 Wall Streets Analysts.

How can I buy shares of OMCL?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Omnicell (OMCL) Stock Forecast & Price Target

OMCL Analyst Ratings

OMCL Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Omnicell

OMCL Analyst Recommendation Trends

OMCL Financial Forecast

OMCL Earnings Forecast

OMCL Sales Forecast

OMCL Stock Forecast FAQ

Detailed List of Analyst Forecasts